Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 239

1.

Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes.

Brown SA, Kovatchev BP, Raghinaru D, Lum JW, Buckingham BA, Kudva YC, Laffel LM, Levy CJ, Pinsker JE, Wadwa RP, Dassau E, Doyle FJ 3rd, Anderson SM, Church MM, Dadlani V, Ekhlaspour L, Forlenza GP, Isganaitis E, Lam DW, Kollman C, Beck RW; iDCL Trial Research Group.

N Engl J Med. 2019 Oct 16. doi: 10.1056/NEJMoa1907863. [Epub ahead of print]

PMID:
31618560
2.

Safety and Performance of the Omnipod Hybrid Closed-Loop System in Adults, Adolescents, and Children with Type 1 Diabetes Over 5 Days Under Free-Living Conditions.

Sherr J, Buckingham BA, Forlenza G, Galderisi A, Ekhlaspour L, Wadwa RP, Carria L, Hsu LJ, Berget CL, Peyser TA, Lee JB, O'Connor J, Dumais B, Huyett LM, Layne JE, Ly TT.

Diabetes Technol Ther. 2019 Oct 9. doi: 10.1089/dia.2019.0286. [Epub ahead of print]

PMID:
31596130
3.

One Year Clinical Experience of the First Commercial Hybrid Closed-Loop.

Lal RA, Basina M, Maahs DM, Hood K, Buckingham B, Wilson DM.

Diabetes Care. 2019 Sep 23. pii: dc190855. doi: 10.2337/dc19-0855. [Epub ahead of print]

PMID:
31548247
4.

Fluoroscopic-assisted laparoscopic retrieval of retained glucose sensor wire from the omentum.

Sang AX, Lal R, August A, Danzer E, Buckingham B, Mueller CM.

Clin Case Rep. 2019 Aug 4;7(9):1717-1720. doi: 10.1002/ccr3.2348. eCollection 2019 Sep.

5.

Feasibility Studies of an Insulin-Only Bionic Pancreas in a Home-Use Setting.

Ekhlaspour L, Nally LM, El-Khatib FH, Ly TT, Clinton P, Frank E, Tanenbaum ML, Hanes SJ, Selagamsetty RR, Hood K, Damiano ER, Buckingham BA.

J Diabetes Sci Technol. 2019 Aug 30:1932296819872225. doi: 10.1177/1932296819872225. [Epub ahead of print]

PMID:
31470740
6.

Realizing a Closed-Loop (Artificial Pancreas) System for the Treatment of Type 1 Diabetes.

Lal RA, Ekhlaspour L, Hood K, Buckingham B.

Endocr Rev. 2019 Jul 5. pii: er.2018-00174. doi: 10.1210/er.2018-00174. [Epub ahead of print]

PMID:
31276160
7.

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.

Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, Bosi E, Buckingham BA, Cefalu WT, Close KL, Cobelli C, Dassau E, DeVries JH, Donaghue KC, Dovc K, Doyle FJ 3rd, Garg S, Grunberger G, Heller S, Heinemann L, Hirsch IB, Hovorka R, Jia W, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Levine B, Mayorov A, Mathieu C, Murphy HR, Nimri R, Nørgaard K, Parkin CG, Renard E, Rodbard D, Saboo B, Schatz D, Stoner K, Urakami T, Weinzimer SA, Phillip M.

Diabetes Care. 2019 Aug;42(8):1593-1603. doi: 10.2337/dci19-0028. Epub 2019 Jun 8. Review.

8.

Assessing the efficacy, safety and utility of 6-month day-and-night automated closed-loop insulin delivery under free-living conditions compared with insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, multicentre, multinational, single-period, randomised, parallel group study protocol.

Musolino G, Allen JM, Hartnell S, Wilinska ME, Tauschmann M, Boughton C, Campbell F, Denvir L, Trevelyan N, Wadwa P, DiMeglio L, Buckingham BA, Weinzimer S, Acerini CL, Hood K, Fox S, Kollman C, Sibayan J, Borgman S, Cheng P, Hovorka R.

BMJ Open. 2019 Jun 3;9(6):e027856. doi: 10.1136/bmjopen-2018-027856.

9.

A Review of Continuous Glucose Monitoring Data Interpretation in the Age of Automated Insulin Delivery.

Ekhlaspour L, Tabatabai I, Buckingham B.

J Diabetes Sci Technol. 2019 Jul;13(4):645-663. doi: 10.1177/1932296819851790. Epub 2019 May 26.

PMID:
31130007
10.

Optimizing the use of continuous glucose monitoring in young children with type 1 diabetes with an adaptive study design and multiple randomizations.

Berget C, Driscoll KA, Lagges A, Lange S, DiMeglio LA, Hannon TS, Woerner SE, Iturralde E, Barley RC, Hanes S, Hood KK, Buckingham BB; Toddler Diabetes Technology Study Group.

Contemp Clin Trials. 2019 Jul;82:60-65. doi: 10.1016/j.cct.2019.05.008. Epub 2019 May 23.

PMID:
31129370
11.

Closed loop control in adolescents and children during winter sports: Use of the Tandem Control-IQ AP system.

Ekhlaspour L, Forlenza GP, Chernavvsky D, Maahs DM, Wadwa RP, Deboer MD, Messer LH, Town M, Pinnata J, Kruse G, Kovatchev BP, Buckingham BA, Breton MD.

Pediatr Diabetes. 2019 Sep;20(6):759-768. doi: 10.1111/pedi.12867. Epub 2019 May 23.

12.

Hybrid Closed-Loop Control Is Safe and Effective for People with Type 1 Diabetes Who Are at Moderate to High Risk for Hypoglycemia.

Anderson SM, Buckingham BA, Breton MD, Robic JL, Barnett CL, Wakeman CA, Oliveri MC, Brown SA, Ly TT, Clinton PK, Hsu LJ, Kingman RS, Norlander LM, Loebner SE, Reuschel-DiVirglio S, Kovatchev BP.

Diabetes Technol Ther. 2019 Jun;21(6):356-363. doi: 10.1089/dia.2019.0018. Epub 2019 May 16.

PMID:
31095423
13.

Performance of Omnipod Personalized Model Predictive Control Algorithm with Moderate Intensity Exercise in Adults with Type 1 Diabetes.

Forlenza GP, Buckingham BA, Christiansen MP, Wadwa RP, Peyser TA, Lee JB, O'Connor J, Dassau E, Huyett LM, Layne JE, Ly TT.

Diabetes Technol Ther. 2019 May;21(5):265-272. doi: 10.1089/dia.2019.0017. Epub 2019 Mar 29.

14.

Successful At-Home Use of the Tandem Control-IQ Artificial Pancreas System in Young Children During a Randomized Controlled Trial.

Forlenza GP, Ekhlaspour L, Breton M, Maahs DM, Wadwa RP, DeBoer M, Messer LH, Town M, Pinnata J, Kruse G, Buckingham BA, Cherñavvsky D.

Diabetes Technol Ther. 2019 Apr;21(4):159-169. doi: 10.1089/dia.2019.0011. Epub 2019 Mar 19.

PMID:
30888835
15.

A Feasibility Study to Detect Neonatal Hypoglycemia in Infants of Diabetic Mothers Using Real-Time Continuous Glucose Monitoring.

Nally LM, Bondy N, Doiev J, Buckingham BA, Wilson DM.

Diabetes Technol Ther. 2019 Apr;21(4):170-176. doi: 10.1089/dia.2018.0337. Epub 2019 Mar 6.

PMID:
30839229
16.

The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component Interoperability.

Anderson SM, Dassau E, Raghinaru D, Lum J, Brown SA, Pinsker JE, Church MM, Levy C, Lam D, Kudva YC, Buckingham B, Forlenza GP, Wadwa RP, Laffel L, Doyle FJ 3rd, DeVries JH, Renard E, Cobelli C, Boscari F, Del Favero S, Kovatchev BP.

Diabetes Technol Ther. 2019 Feb;21(2):73-80. doi: 10.1089/dia.2018.0308. Epub 2019 Jan 16.

PMID:
30649925
17.

Safety Evaluation of the MiniMed 670G System in Children 7-13 Years of Age with Type 1 Diabetes.

Forlenza GP, Pinhas-Hamiel O, Liljenquist DR, Shulman DI, Bailey TS, Bode BW, Wood MA, Buckingham BA, Kaiserman KB, Shin J, Huang S, Lee SW, Kaufman FR.

Diabetes Technol Ther. 2019 Jan;21(1):11-19. doi: 10.1089/dia.2018.0264. Epub 2018 Dec 26.

18.

In-Clinic Evaluation of the MiniMed 670G System "Suspend Before Low" Feature in Children with Type 1 Diabetes.

Wood MA, Shulman DI, Forlenza GP, Bode BW, Pinhas-Hamiel O, Buckingham BA, Kaiserman KB, Liljenquist DR, Bailey TS, Shin J, Huang S, Chen X, Cordero TL, Lee SW, Kaufman FR.

Diabetes Technol Ther. 2018 Nov;20(11):731-737. doi: 10.1089/dia.2018.0209. Epub 2018 Oct 6.

PMID:
30299976
19.

Psychosocial and Human Factors During a Trial of a Hybrid Closed Loop System for Type 1 Diabetes Management.

Adams RN, Tanenbaum ML, Hanes SJ, Ambrosino JM, Ly TT, Maahs DM, Naranjo D, Walders-Abramson N, Weinzimer SA, Buckingham BA, Hood KK.

Diabetes Technol Ther. 2018 Oct;20(10):648-653. doi: 10.1089/dia.2018.0174. Epub 2018 Sep 21.

PMID:
30239219
20.

Review and update of the Health of the Nation Outcome Scales for Elderly People (HoNOS65+).

James M, Buckingham B, Cheung G, McKay R, Painter J, Stewart MW.

BJPsych Bull. 2018 Dec;42(6):248-252. doi: 10.1192/bjb.2018.68. Epub 2018 Sep 17.

21.

Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial.

Forlenza GP, Li Z, Buckingham BA, Pinsker JE, Cengiz E, Wadwa RP, Ekhlaspour L, Church MM, Weinzimer SA, Jost E, Marcal T, Andre C, Carria L, Swanson V, Lum JW, Kollman C, Woodall W, Beck RW.

Diabetes Care. 2018 Oct;41(10):2155-2161. doi: 10.2337/dc18-0771. Epub 2018 Aug 8.

PMID:
30089663
22.

Performance of the Omnipod Personalized Model Predictive Control Algorithm with Meal Bolus Challenges in Adults with Type 1 Diabetes.

Buckingham BA, Christiansen MP, Forlenza GP, Wadwa RP, Peyser TA, Lee JB, O'Connor J, Dassau E, Huyett LM, Layne JE, Ly TT.

Diabetes Technol Ther. 2018 Sep;20(9):585-595. doi: 10.1089/dia.2018.0138. Epub 2018 Aug 2.

23.

Sustained Continuous Glucose Monitor Use in Low-Income Youth with Type 1 Diabetes Following Insurance Coverage Supports Expansion of Continuous Glucose Monitor Coverage for All.

Prahalad P, Addala A, Buckingham BA, Wilson DM, Maahs DM.

Diabetes Technol Ther. 2018 Sep;20(9):632-634. doi: 10.1089/dia.2018.0204. Epub 2018 Jul 18. No abstract available.

24.

ISPAD Clinical Practice Consensus Guidelines 2018: Insulin treatment in children and adolescents with diabetes.

Danne T, Phillip M, Buckingham BA, Jarosz-Chobot P, Saboo B, Urakami T, Battelino T, Hanas R, Codner E.

Pediatr Diabetes. 2018 Oct;19 Suppl 27:115-135. doi: 10.1111/pedi.12718. No abstract available.

PMID:
29999222
25.

Large Changes in Brain Volume Observed in an Asymptomatic Young Child With Type 1 Diabetes.

Mazaika PK, Aye T, Reiss AL, Buckingham BA.

Diabetes Care. 2018 Jul;41(7):1535-1537. doi: 10.2337/dc17-2503. No abstract available.

26.

Advances in Care for Insulin-Requiring Patients Without Closed Loop.

Lal RA, Buckingham B, Maahs DM.

Diabetes Technol Ther. 2018 Jun;20(S2):S285-S291. doi: 10.1089/dia.2018.0084. No abstract available.

27.

Fully Closed-Loop Multiple Model Probabilistic Predictive Controller Artificial Pancreas Performance in Adolescents and Adults in a Supervised Hotel Setting.

Forlenza GP, Cameron FM, Ly TT, Lam D, Howsmon DP, Baysal N, Kulina G, Messer L, Clinton P, Levister C, Patek SD, Levy CJ, Wadwa RP, Maahs DM, Bequette BW, Buckingham BA.

Diabetes Technol Ther. 2018 May;20(5):335-343. doi: 10.1089/dia.2017.0424. Epub 2018 Apr 16.

28.

Persistence of abnormalities in white matter in children with type 1 diabetes.

Fox LA, Hershey T, Mauras N, Arbeláez AM, Tamborlane WV, Buckingham B, Tsalikian E, Englert K, Raman M, Jo B, Shen H, Reiss A, Mazaika P; Diabetes Research in Children Network (DirecNet).

Diabetologia. 2018 Jul;61(7):1538-1547. doi: 10.1007/s00125-018-4610-6. Epub 2018 Apr 13.

29.

Glucose sensor-augmented continuous subcutaneous insulin infusion in patients with diabetic gastroparesis: An open-label pilot prospective study.

Calles-Escandón J, Koch KL, Hasler WL, Van Natta ML, Pasricha PJ, Tonascia J, Parkman HP, Hamilton F, Herman WH, Basina M, Buckingham B, Earle K, Kirkeby K, Hairston K, Bright T, Rothberg AE, Kraftson AT, Siraj ES, Subauste A, Lee LA, Abell TL, McCallum RW, Sarosiek I, Nguyen L, Fass R, Snape WJ, Vaughn IA, Miriel LA, Farrugia G; NIDDK Gastroparesis Clinical Research Consortium (GpCRC).

PLoS One. 2018 Apr 13;13(4):e0194759. doi: 10.1371/journal.pone.0194759. eCollection 2018.

30.

A review and update of the Health of the Nation Outcome Scales (HoNOS).

James M, Painter J, Buckingham B, Stewart MW.

BJPsych Bull. 2018 Apr;42(2):63-68. doi: 10.1192/bjb.2017.17. Epub 2018 Mar 5.

31.

Optimizing Hybrid Closed-Loop Therapy in Adolescents and Emerging Adults Using the MiniMed 670G System.

Messer LH, Forlenza GP, Sherr JL, Wadwa RP, Buckingham BA, Weinzimer SA, Maahs DM, Slover RH.

Diabetes Care. 2018 Apr;41(4):789-796. doi: 10.2337/dc17-1682. Epub 2018 Feb 14.

32.

Safety and Feasibility of the OmniPod Hybrid Closed-Loop System in Adult, Adolescent, and Pediatric Patients with Type 1 Diabetes Using a Personalized Model Predictive Control Algorithm.

Buckingham BA, Forlenza GP, Pinsker JE, Christiansen MP, Wadwa RP, Schneider J, Peyser TA, Dassau E, Lee JB, O'Connor J, Layne JE, Ly TT.

Diabetes Technol Ther. 2018 Apr;20(4):257-262. doi: 10.1089/dia.2017.0346. Epub 2018 Feb 12.

33.

Real-Time Detection of Infusion Site Failures in a Closed-Loop Artificial Pancreas.

Howsmon DP, Baysal N, Buckingham BA, Forlenza GP, Ly TT, Maahs DM, Marcal T, Towers L, Mauritzen E, Deshpande S, Huyett LM, Pinsker JE, Gondhalekar R, Doyle FJ 3rd, Dassau E, Hahn J, Bequette BW.

J Diabetes Sci Technol. 2018 May;12(3):599-607. doi: 10.1177/1932296818755173. Epub 2018 Feb 1.

34.

A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System to Manage Children and Adolescents With Diabetes.

Laffel LM, Aleppo G, Buckingham BA, Forlenza GP, Rasbach LE, Tsalikian E, Weinzimer SA, Harris DR.

J Endocr Soc. 2017 Nov 20;1(12):1461-1476. doi: 10.1210/js.2017-00389. eCollection 2017 Dec 1.

35.

Application of Glycemic Variability Percentage: Implications for Continuous Glucose Monitor Utilization and Analysis of Artificial Pancreas Data.

Garcia A, Balo AK, Buckingham BA, Hirsch IB, Peyser TA.

Diabetes Technol Ther. 2017 Dec;19(12):699-706. doi: 10.1089/dia.2017.0188.

PMID:
29243959
36.

Glycemic Variability Percentage: A Novel Method for Assessing Glycemic Variability from Continuous Glucose Monitor Data.

Peyser TA, Balo AK, Buckingham BA, Hirsch IB, Garcia A.

Diabetes Technol Ther. 2018 Jan;20(1):6-16. doi: 10.1089/dia.2017.0187. Epub 2017 Dec 11.

37.

International Consensus on Use of Continuous Glucose Monitoring.

Danne T, Nimri R, Battelino T, Bergenstal RM, Close KL, DeVries JH, Garg S, Heinemann L, Hirsch I, Amiel SA, Beck R, Bosi E, Buckingham B, Cobelli C, Dassau E, Doyle FJ 3rd, Heller S, Hovorka R, Jia W, Jones T, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Maahs D, Murphy HR, Nørgaard K, Parkin CG, Renard E, Saboo B, Scharf M, Tamborlane WV, Weinzimer SA, Phillip M.

Diabetes Care. 2017 Dec;40(12):1631-1640. doi: 10.2337/dc17-1600. Review.

38.

Predictive hyperglycemia and hypoglycemia minimization: In-home double-blind randomized controlled evaluation in children and young adolescents.

Forlenza GP, Raghinaru D, Cameron F, Wayne Bequette B, Peter Chase H, Paul Wadwa R, Maahs DM, Jost E, Ly TT, Wilson DM, Norlander L, Ekhlaspour L, Min H, Clinton P, Njeru N, Lum JW, Kollman C, Beck RW, Buckingham BA; In-Home Closed-Loop (IHCL) Study Group.

Pediatr Diabetes. 2018 May;19(3):420-428. doi: 10.1111/pedi.12603. Epub 2017 Nov 20.

39.

Liver Scaffolds Support Survival and Metabolic Function of Multilineage Neonatal Allogenic Cells.

Hassanein W, Cimeno A, Werdesheim A, Buckingham B, Harrison J, Uluer MC, Khalifeh A, Rivera-Pratt C, Klepfer S, Woodall JD, Dhru U, Bromberg E, Parsell D, Drachenberg C, Barth RN, LaMattina JC.

Tissue Eng Part A. 2018 May;24(9-10):786-793. doi: 10.1089/ten.TEA.2017.0279. Epub 2017 Nov 30.

PMID:
29017397
40.

Erratum. Application of Zone Model Predictive Control Artificial Pancreas During Extended Use of Infusion Set and Sensor: A Randomized Crossover-Controlled Home-Use Trial. Diabetes Care 2017;40:1096-1102.

Forlenza GP, Deshpande S, Ly TT, Howsmon DP, Cameron F, Baysal N, Mauritzen E, Marcal T, Towers L, Bequette BW, Huyett LM, Pinsker JE, Gondhalekar R, Doyle FJ 3rd, Maahs DM, Buckingham BA, Dassau E.

Diabetes Care. 2017 Nov;40(11):1606. doi: 10.2337/dc17-er11a. Epub 2017 Sep 8. No abstract available.

41.

Trust in hybrid closed loop among people with diabetes: Perspectives of experienced system users.

Tanenbaum ML, Iturralde E, Hanes SJ, Suttiratana SC, Ambrosino JM, Ly TT, Maahs DM, Naranjo D, Walders-Abramson N, Weinzimer SA, Buckingham BA, Hood KK.

J Health Psychol. 2017 Jul 1:1359105317718615. doi: 10.1177/1359105317718615. [Epub ahead of print]

PMID:
28810490
42.

Closed-Loop Control Without Meal Announcement in Type 1 Diabetes.

Cameron FM, Ly TT, Buckingham BA, Maahs DM, Forlenza GP, Levy CJ, Lam D, Clinton P, Messer LH, Westfall E, Levister C, Xie YY, Baysal N, Howsmon D, Patek SD, Bequette BW.

Diabetes Technol Ther. 2017 Sep;19(9):527-532. doi: 10.1089/dia.2017.0078. Epub 2017 Aug 2.

43.

Estimating the number of adults with severe and persistent mental illness who have complex, multi-agency needs.

Whiteford H, Buckingham B, Harris M, Diminic S, Stockings E, Degenhardt L.

Aust N Z J Psychiatry. 2017 Aug;51(8):799-809. doi: 10.1177/0004867416683814. Epub 2016 Dec 21.

PMID:
28718716
44.

The dawn of automated insulin delivery: A new clinical framework to conceptualize insulin administration.

Messer LH, Forlenza GP, Wadwa RP, Weinzimer SA, Sherr JL, Hood KK, Buckingham BA, Slover RH, Maahs DM.

Pediatr Diabetes. 2018 Feb;19(1):14-17. doi: 10.1111/pedi.12535. Epub 2017 Jun 27. No abstract available.

PMID:
28656656
45.

A Simple Composite Metric for the Assessment of Glycemic Status from Continuous Glucose Monitoring Data: Implications for Clinical Practice and the Artificial Pancreas.

Hirsch IB, Balo AK, Sayer K, Garcia A, Buckingham BA, Peyser TA.

Diabetes Technol Ther. 2017 Jun;19(S3):S38-S48. doi: 10.1089/dia.2017.0080.

46.

Application of Zone Model Predictive Control Artificial Pancreas During Extended Use of Infusion Set and Sensor: A Randomized Crossover-Controlled Home-Use Trial.

Forlenza GP, Deshpande S, Ly TT, Howsmon DP, Cameron F, Baysal N, Mauritzen E, Marcal T, Towers L, Bequette BW, Huyett LM, Pinsker JE, Gondhalekar R, Doyle FJ 3rd, Maahs DM, Buckingham BA, Dassau E.

Diabetes Care. 2017 Aug;40(8):1096-1102. doi: 10.2337/dc17-0500. Epub 2017 Jun 5. Erratum in: Diabetes Care. 2017 Sep 8;:.

47.

Outpatient Closed-Loop Control with Unannounced Moderate Exercise in Adolescents Using Zone Model Predictive Control.

Huyett LM, Ly TT, Forlenza GP, Reuschel-DiVirgilio S, Messer LH, Wadwa RP, Gondhalekar R, Doyle FJ 3rd, Pinsker JE, Maahs DM, Buckingham BA, Dassau E.

Diabetes Technol Ther. 2017 Jun;19(6):331-339. doi: 10.1089/dia.2016.0399. Epub 2017 May 1.

48.

Expectations and Attitudes of Individuals With Type 1 Diabetes After Using a Hybrid Closed Loop System.

Iturralde E, Tanenbaum ML, Hanes SJ, Suttiratana SC, Ambrosino JM, Ly TT, Maahs DM, Naranjo D, Walders-Abramson N, Weinzimer SA, Buckingham BA, Hood KK.

Diabetes Educ. 2017 Apr;43(2):223-232. doi: 10.1177/0145721717697244.

PMID:
28340542
49.

Evaluation of a Predictive Low-Glucose Management System In-Clinic.

Buckingham BA, Bailey TS, Christiansen M, Garg S, Weinzimer S, Bode B, Anderson SM, Brazg R, Ly TT, Kaufman FR.

Diabetes Technol Ther. 2017 May;19(5):288-292. doi: 10.1089/dia.2016.0319. Epub 2017 Feb 16.

PMID:
28221823
50.

Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes.

Garg SK, Weinzimer SA, Tamborlane WV, Buckingham BA, Bode BW, Bailey TS, Brazg RL, Ilany J, Slover RH, Anderson SM, Bergenstal RM, Grosman B, Roy A, Cordero TL, Shin J, Lee SW, Kaufman FR.

Diabetes Technol Ther. 2017 Mar;19(3):155-163. doi: 10.1089/dia.2016.0421. Epub 2017 Jan 30.

Supplemental Content

Loading ...
Support Center